BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07024706-completion@plaintrial.com
DTSTAMP:20261029T055731Z
DTSTART;VALUE=DATE:20330323
SUMMARY:Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+
 Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab —
  estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07024706
URL:https://plaintrial.com/trial/NCT07024706
END:VEVENT
END:VCALENDAR